approved treatments for hepatitis B virus (HBV) infection include the immunomodulatory agent IFN-α and nucleos(t)ide analogues. (= 0.002) for hepatitis B e (HBe) antigen. Serum HBV DNA levels were below 400 copies/mL in 54% (= 167) of the emtricitabine group and only 2% (= 81) of the placebo group (< 0.001) while alanine aminotransferase levels… Continue reading approved treatments for hepatitis B virus (HBV) infection include the immunomodulatory